Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Directorate Change

16 Oct 2019 16:11

RNS Number : 1333Q
Cenkos Securities PLC
16 October 2019
Β 

16 October 2019

Β 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 ("MAR").

Β 

Β 

Cenkos Securities plc

("Cenkos" or the "Company")

Β 

Directorate Change

Β 

The Board of Cenkos is pleased to announce the appointment of Julian Morse, as an Executive Director of the Company. This appointment is subject to Financial Conduct Authority approval and will take effect on the receipt of regulatory consent.

Β 

Julian is Head of the Cenkos Growth Companies Team and has led that team since 2016. He is one of the founding members of the team having joined Cenkos in 2006. He has over 25 years' experience in the City where he has advised and raised equity on IPO's and secondary fund raisings for a wide range of companies across a broad range of sectors. Previously, Julian was a Director at Beeson Gregory and Evolution Securities.

Commenting on the appointment, Jeff Hewitt Acting Chairman of the Company, said:

"I am delighted that Julian has agreed to join the Board. With Julian's experience and proven success in managing the Growth Companies team he will provide a valuable addition to the Board and will assist in driving the whole business forward."

Additional Information

Β 

In accordance with the AIM Rules, the following information is required to be disclosed in relation to Julian Morse is set out below. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules.

Β 

Full Name and age:

Julian Jonathan Morse aged 48

Β 

Current Directorships/Partnerships:

None

Β 

Previous Directorships/Partnerships:

Dovemoat LLP - LLP member resigned 17 November 2015

Β 

Current interest in the Company's share capital:

403,239 Ordinary shares of 1 pence held under his Self-Invested Personal Pension

384,501 Ordinary shares of 1 pence held in accordance with the terms and conditions of Company's Deferred Bonus Scheme

18,842 Ordinary shares of 1 pence shares held in the Company's Share Incentive Plan of which X are subject to forfeiture

Β 

Options over 185,220 Ordinary shares held under the Compensatory Award Plan Options. These options are at 169.0 pence. These options expire on 22 October 2019.

Β 

Options over 21,094 Ordinary shares held under the Company's Save As You Earn Plan. These options are at 85.3 pence. These options expire on 30 November 2021.

Β 

Β 

Β 

Β 

Enquiries:

Β 

Cenkos Securities plc

Jim Durkin, Chief Executive Officer

Β 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis,Β Nominated Adviser

Β 

Tel:Β 0203 368 3552

Whitman Howard Limited

Nick Lovering,Β Broker

Β 

Tel:Β 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

Tel:Β 0207 466 5066

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOABUBDGRGBBGCL
Date   Source Headline
17th Mar 202210:14 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 20228:48 amRNSForm 8.5 (EPT/NON-RI)
14th Mar 20228:27 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 20228:37 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 20228:33 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20229:23 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20229:09 amRNSForm 8.5 (EPT/NON-RI)
8th Mar 20221:29 pmRNSForm 8.5 (EPT/NON-RI)
8th Mar 20221:26 pmRNSForm 8.5 (EPT/NON-RI)
8th Mar 20229:01 amRNSForm 8.5 (EPT/NON-RI)
7th Mar 20229:10 amRNSForm 8.5 (EPT/NON-RI)
4th Mar 20229:32 amRNSForm 8.5 (EPT/NON-RI)
3rd Mar 20228:40 amRNSForm 8.5 (EPT/NON-RI)
2nd Mar 20228:35 amRNSForm 8.5 (EPT/NON-RI)
1st Mar 20229:03 amRNSForm 8.5 (EPT/NON-RI)
28th Feb 20229:07 amRNSForm 8.5 (EPT/NON-RI)
25th Feb 20229:27 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 20228:42 amRNSForm 8.5 (EPT/NON-RI)
21st Feb 20228:44 amRNSForm 8.5 (EPT/NON-RI)
21st Feb 20228:44 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 20228:30 amRNSForm 8.5 (EPT/NON-RI)
15th Feb 20228:40 amRNSForm 8.5 (EPT/NON-RI)
15th Feb 20228:38 amRNSForm 8.5 (EPT/NON-RI)
14th Feb 20229:16 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20229:24 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20229:22 amRNSForm 8.5 (EPT/NON-RI)
31st Jan 20229:01 amRNSForm 8.5 (EPT/NON-RI)
28th Jan 20228:34 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20228:17 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20229:00 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20228:55 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20228:42 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 202210:36 amRNSForm 8.5 (EPT/NON-RI)
23rd Dec 20213:39 pmRNSRenewal of the EBT Share Purchase Plan
8th Dec 20218:56 amRNSForm 8.5 (EPT/NON-RI)
26th Nov 20218:37 amRNSForm 8.5 (EPT/NON-RI)
25th Nov 20219:00 amRNSForm 8.5 (EPT/NON-RI)
2nd Nov 202110:14 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20219:05 amRNSForm 8.5 (EPT/NON-RI)
29th Oct 20211:40 pmRNSBlock Listing Interim Review
28th Oct 202110:25 amRNSForm 8.5 (EPT/NON-RI)
27th Oct 20219:22 amRNSForm 8.5 (EPT/NON-RI)
26th Oct 20218:49 amRNSForm 8.5 (EPT/NON-RI)
25th Oct 20218:30 amRNSForm 8.5 (EPT/NON-RI)
21st Oct 20218:46 amRNSForm 8.5 (EPT/NON-RI)
9th Sep 20217:00 amRNSInterim Results
3rd Sep 20218:43 amRNSForm 8.5 (EPT/NON-RI)
2nd Sep 20218:31 amRNSForm 8.5 (EPT/NON-RI)
1st Sep 20218:30 amRNSForm 8.5 (EPT/NON-RI)
31st Aug 20219:56 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.